Liquidia (LQDA) Free Cash Flow (QoQ) (2020 - 2026)
Liquidia (LQDA) Free Cash Flow (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.87 Bn | 42.91 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.21 Bn | 39.55 Bn | 2.15 Bn |
| 3 | Zoetis | 31.48 Bn | 29.80 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.49 Bn | 15.10 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Liquidia | 6.36 Bn | 6.08 Bn | 160.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 56.81% |
| Mar 31, 2026 | 4.78% |
| Dec 31, 2025 | 514.65% |
| Sep 30, 2025 | 70.53% |
| Jun 30, 2025 | -2.67% |
| Mar 31, 2025 | -103.33% |
| Dec 31, 2024 | 38.23% |
| Sep 30, 2024 | -24.88% |
| Jun 30, 2024 | 12.25% |
| Mar 31, 2024 | -58.46% |
| Dec 31, 2023 | -34.50% |
| Sep 30, 2023 | -107.27% |
| Jun 30, 2023 | 34.18% |
| Mar 31, 2023 | -73.20% |
| Dec 31, 2022 | 13.19% |
| Sep 30, 2022 | 30.47% |
| Jun 30, 2022 | 13.68% |
| Mar 31, 2022 | -29.01% |
| Dec 31, 2021 | -29.98% |
| Sep 30, 2021 | 30.46% |